Insertion in the N-Terminal Domain of the SARS-CoV-2 Spike Glycoprotein Affects Antibody Recognition and Phenotypic Properties
Viruses · 2026
DOI: 10.3390/v18030277 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2026. Verfasst von Elena A Ermolaeva und 10 weiteren Autor:innen. Beteiligte Einrichtung: Chumakov FSC R&D IBP RAS (Institute of Poliomyelitis), 108819 Moscow, Russia. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, Antibodies, Viral, SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the State Assignment.
Abstract (Originalsprache)
SARS-CoV-2, which causes COVID-19, continues to circulate around the world, making it necessary to study the impact of rapidly emerging mutations on escape from neutralizing antibodies and pathogenesis. While RBD mutations are well characterized, mutations in the N-terminal domain (NTD) of the spike protein remain comparatively understudied despite their relevance to antibody recognition. This study investigates two phenotypically distinct SARS-CoV-2 mutants, which exhibited differences in plaque morphology on Vero cells. Whole-genome sequencing via Illumina identified a novel 12-nucleotide insertion in the spike NTD. This insertion induced a frameshift, introducing five new amino acids potentially altering viral behavior, receptor interactions, and antibody detection in ELISAs. The study further explores the pathogenicity of these variants in a hamster model. These findings underscore the importance of monitoring NTD mutations, which may contribute to immune evasion and influence therapeutic antibody efficacy, highlighting gaps in current research on SARS-CoV-2 evolution.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chumakov FSC R&D IBP RAS (Institute of Poliomyelitis), 108819 Moscow, Russia.
- Institute for Translational Medicine and Biotechnology, First Moscow State Medical University (Sechenov University), 117418 Moscow, Russia.
- Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119991 Moscow, Russia.
ORCID-Profile: Elena A Ermolaeva, Anna N Zyrina, Anton S Motov, Olga S Gancharova, Liubov I Kozlovskaya
Förderung
- the State Assignment
Zitieren
APA
Ermolaeva, E. A., Zyrina, A. N., Sirazova, D. I., Lunin, A. S., Motov, A. S., Chernavtseva, A. D., Gancharova, O. S., Kozlovskaya, L. I., Shishova, A. A., Siniugina, A. A., & Ishmukhametov, A. A. (2026). Insertion in the N-Terminal Domain of the SARS-CoV-2 Spike Glycoprotein Affects Antibody Recognition and Phenotypic Properties. Viruses. https://doi.org/10.3390/v18030277
Vancouver
Ermolaeva EA, Zyrina AN, Sirazova DI, Lunin AS, Motov AS, Chernavtseva AD, et al. Insertion in the N-Terminal Domain of the SARS-CoV-2 Spike Glycoprotein Affects Antibody Recognition and Phenotypic Properties. Viruses. 2026. doi:10.3390/v18030277
BibTeX
@article{Ermolaeva2026,
author = {Ermolaeva, Elena A and Zyrina, Anna N and Sirazova, Dina I and Lunin, Alexander S and Motov, Anton S and Chernavtseva, Anastasia D and Gancharova, Olga S and Kozlovskaya, Liubov I and Shishova, Anna A and Siniugina, Alexandra A and Ishmukhametov, Aydar A},
title = {Insertion in the N-Terminal Domain of the SARS-CoV-2 Spike Glycoprotein Affects Antibody Recognition and Phenotypic Properties},
journal = {Viruses},
year = {2026},
doi = {10.3390/v18030277}
}
EUVIMED